These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

998 related items for PubMed ID: 18510351

  • 1. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M, Berger S, Poethko T, Schwaiger M, Wester HJ.
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [Abstract] [Full Text] [Related]

  • 2. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.
    Schottelius M, Poethko T, Herz M, Reubi JC, Kessler H, Schwaiger M, Wester HJ.
    Clin Cancer Res; 2004 Jun 01; 10(11):3593-606. PubMed ID: 15173065
    [Abstract] [Full Text] [Related]

  • 3. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL, Honer M, Lam PY, Mindt TL, Groehn V, Schibli R, Schubiger PA, Ametamey SM.
    Bioconjug Chem; 2008 Dec 01; 19(12):2462-70. PubMed ID: 19053298
    [Abstract] [Full Text] [Related]

  • 4. Extracellular loop 3 (EL3) and EL3-proximal transmembrane helix 7 of the mammalian type I and type II gonadotropin-releasing hormone (GnRH) receptors determine differential ligand selectivity to GnRH-I and GnRH-II.
    Li JH, Choe H, Wang AF, Maiti K, Wang C, Salam A, Chun SY, Lee WK, Kim K, Kwon HB, Seong JY.
    Mol Pharmacol; 2005 Apr 01; 67(4):1099-110. PubMed ID: 15635044
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and Evaluation of 18F-Labeled Peptide for Gonadotropin-Releasing Hormone Receptor Imaging.
    Huang S, Li H, Han Y, Fu L, Ren Y, Zhang Y, Li Y, Sun P, Wang M, Wu H, Wang Q, Hu K.
    Contrast Media Mol Imaging; 2019 Apr 01; 2019():5635269. PubMed ID: 30983920
    [Abstract] [Full Text] [Related]

  • 6. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [Abstract] [Full Text] [Related]

  • 7. Identification of new gonadotrophin-releasing hormone partial agonists.
    Leaños-Miranda A, Ulloa-Aguirre A, Cervini LA, Janovick JA, Rivier J, Conn PM.
    J Endocrinol; 2006 Jun 01; 189(3):509-17. PubMed ID: 16731782
    [Abstract] [Full Text] [Related]

  • 8. Preparation of a radiolabeled GnRH-I analogue derivative with 111 In as a new anti-proliferative agent.
    Zoghi M, Nosrati SA, Rogni F, Rajabifar S.
    J Labelled Comp Radiopharm; 2018 Oct 01; 61(12):903-911. PubMed ID: 30109712
    [Abstract] [Full Text] [Related]

  • 9. Preclinical evaluation of new GnRH-I receptor radionuclide therapy with 177 Lu-peptide tracer.
    Zoghi M, Attar Nosrati S, Rogni F, Shirvani G, Johari Daha F.
    J Labelled Comp Radiopharm; 2019 Jun 15; 62(7):310-320. PubMed ID: 31033025
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
    Däpp S, García Garayoa E, Maes V, Brans L, Tourwé DA, Müller C, Schibli R.
    Nucl Med Biol; 2011 Oct 15; 38(7):997-1009. PubMed ID: 21982571
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo comparison of human Escherichia coli heat-stable peptide analogues incorporating the 111In-DOTA group and distinct linker moieties.
    Giblin MF, Gali H, Sieckman GL, Owen NK, Hoffman TJ, Forte LR, Volkert WA.
    Bioconjug Chem; 2004 Oct 15; 15(4):872-80. PubMed ID: 15264876
    [Abstract] [Full Text] [Related]

  • 15. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
    von Guggenberg E, Behe M, Behr TM, Saurer M, Seppi T, Decristoforo C.
    Bioconjug Chem; 2004 Oct 15; 15(4):864-71. PubMed ID: 15264875
    [Abstract] [Full Text] [Related]

  • 16. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
    Schottelius M, Rau F, Reubi JC, Schwaiger M, Wester HJ.
    Bioconjug Chem; 2005 Oct 15; 16(2):429-37. PubMed ID: 15769098
    [Abstract] [Full Text] [Related]

  • 17. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
    Breeman WA, de Jong M, Erion JL, Bugaj JE, Srinivasan A, Bernard BF, Kwekkeboom DJ, Visser TJ, Krenning EP.
    J Nucl Med; 2002 Dec 15; 43(12):1650-6. PubMed ID: 12468515
    [Abstract] [Full Text] [Related]

  • 18. Introduction of D-phenylalanine enhanced the receptor binding affinities of gonadotropin-releasing hormone peptides.
    Lu J, Hathaway HJ, Royce ME, Prossnitz ER, Miao Y.
    Bioorg Med Chem Lett; 2014 Feb 01; 24(3):725-30. PubMed ID: 24418777
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
    Roosenburg S, Laverman P, Joosten L, Eek A, Oyen WJ, de Jong M, Rutjes FP, van Delft FL, Boerman OC.
    Bioconjug Chem; 2010 Apr 21; 21(4):663-70. PubMed ID: 20302291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.